title: Zebrafish Models of Human Leukemia: Technological Advances and Mechanistic Insights.
abstract: Insights concerning leukemic pathophysiology have been acquired in various animal models and further efforts to understand the mechanisms underlying leukemic treatment resistance and disease relapse promise to improve therapeutic strategies. The zebrafish (Danio rerio) is a vertebrate organism with a conserved hematopoietic program and unique experimental strengths suiting it for the investigation of human leukemia. Recent technological advances in zebrafish research including efficient transgenesis, precise genome editing, and straightforward transplantation techniques have led to the generation of a number of leukemia models. The transparency of the zebrafish when coupled with improved lineage-tracing and imaging techniques has revealed exquisite details of leukemic initiation, progression, and regression. With these advantages, the zebrafish represents a unique experimental system for leukemic research and additionally, advances in zebrafish-based high-throughput drug screening promise to hasten the discovery of novel leukemia therapeutics. To date, investigators have accumulated knowledge of the genetic underpinnings critical to leukemic transformation and treatment resistance and without doubt, zebrafish are rapidly expanding our understanding of disease mechanisms and helping to shape therapeutic strategies for improved outcomes in leukemic patients.
authors.affiliation: Department of Pharmacology and Experimental Therapeutics, Cancer Research Center, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA, USA.
authors.forename: Nicholas R
authors.initials: NR
authors.lastname: Harrison
authors.affiliation: Department of Pharmacology and Experimental Therapeutics, Cancer Research Center, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA, USA.
authors.forename: Fabrice J F
authors.initials: FJ
authors.lastname: Laroche
authors.affiliation: Division of Hematology, Boston Children's Hospital, Boston, MA, USA.
authors.forename: Alejandro
authors.initials: A
authors.lastname: Gutierrez
authors.affiliation: Department of Pharmacology and Experimental Therapeutics, Cancer Research Center, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA, USA. huifeng@bu.edu.
authors.forename: Hui
authors.initials: H
authors.lastname: Feng
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006410:Hematopoiesis; D006801:Humans; D007938:Leukemia / Q000235:genetics / Q000473:pathology*; D015027:Zebrafish
keywords: AML; B-ALL; CLL; CML; Leukemia; T-ALL; Transplantation; Xenograft; Zebrafish